TNXP - Tonix Pharmaceuticals Holding Corp

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

TNXP is currently covered by 1 analysts with average potential upside of $25394.33 (314.21%) backed by 7 price targets and 10 ratings. Documented since 01-Oct-2013. Analyst's average stock valuation to be materialised ratio is 16.67% with an average time for price targets to be met of 76.5 days.

Most recent stock forecast was given by JIM MOLLOY from ALLIANCE GLOBAL PARTNERS on 12-Jan-2023.

Highest price target for TNXP is 6, Lowest price target is 6, average price target is 6.

Best performing analysts who are covering TNXP - Tonix Pharmaceuticals Holding Corp:

Scott Henry Jim Molloy

Currently, out of the existing stock ratings of TNXP - 1 which are a Buy (100%)

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$5.35 (465.22%)

2 months 15 days ago

0/1 (0%)

$5.3 (441.67%)



$1279.42 (220589.66%)


3 years 6 months 25 days ago

2/6 (33.33%)

$50783.36 (186.75%)


Show more analysts

What is TNXP(Tonix Pharmaceuticals Holding Corp) average time for price targets to be met?

On average it took 76.5 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on TNXP(Tonix Pharmaceuticals Holding Corp) with a proven track record?